Literature DB >> 9059555

Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients.

A A Kasperlik-Zeluska1, E Rosłonowska, J Słowinska-Srzednicka, B Migdalska, W Jeske, A Makowska, H Snochowska.   

Abstract

OBJECTIVE: Incidentally discovered adrenal masses are fairly common, although there are some controversies concerning the results of hormonal investigation (especially DHEAS values) and the methods of management. We summarize our experience in diagnosis, pathological findings and treatment of a large group of patients with incidentally found adrenal tumours. DESIGN AND PATIENTS: Our study included patients referred to the Department of Endocrinology of the Centre of Post-graduate Medical Education (Warsaw, Poland) during the last 10 years because of an adrenal tumour incidentally found on ultrasound scan. In all cases this was confirmed by computed tomography. There were 208 patients (148 female and 60 male), 14-76 years old. Unilateral adrenal masses were found in 172 patients (right 106, left 66), while bilateral masses were demonstrated in 36 patients. The size of the tumours ranged between 0.8 and 21.0 cm. The most common clinical abnormalities were hypertension (36 cases), obesity (23 cases), diabetes (8 cases), Addison's disease (6 cases). MEASUREMENTS: Endocrine tests evaluating pituitary-adrenal function (urinary excretion of 17-hydroxycorticosteroids, 17-ketosteroids and catecholamines, plasma concentrations of ACTH, cortisol, DHEAS, androstendione and testosterone, dexamethasone suppression test and corticotrophin-releasing hormone stimulation test).
RESULTS: Cortisol hypersecretion was noted in two patients with coexisting Cushing's disease and high normal 17-OHCS values with lack of dexamethasone suppressibility were found in six other patients with pre-clinical Cushing's syndrome. More common were subtle hormonal abnormalities: low ACTH levels (in 33 out of 98 investigated patients), diminished dexamethasone suppressibility and lack of ACTH response in the CRH test (in two out of 12 patients). Urinary catecholamine excretion was elevated in nine patients. In the group of 85 patients treated by surgery the most frequent pathological findings were: adrenocortical adenoma (21), carcinoma (17), phaeochromocytoma (13), metastatic masses (12) and myelolipoma (10). The size of carcinomas ranged from 3.2 to 20.0 cm, while the size of non-malignant tumours ranged from 1.5 to 21.0 cm.
CONCLUSIONS: Every patient with an incidentally discovered adrenal mass has to be investigated to detect malignancy and subtle hormonal overproduction, to select the cases for surgical treatment. Most of the adrenocortical carcinomas were > 7.0 cm in diameter. For prophylactic purposes, adrenal incidentalomas > 4.0 cm should be treated by surgery, while the smaller ones could be followed-up (with special care for those between 3.0 and 4.0 cm).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059555     DOI: 10.1046/j.1365-2265.1997.d01-1751.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  30 in total

1.  Visualisation of the normal adrenals at SPET examination with 111In-pentetreotide.

Authors:  Hans Jacobsson; Staffan Bremmer; Stig A Larsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-24       Impact factor: 9.236

2.  Correlation between radiologic and pathologic dimensions of adrenal masses.

Authors:  Rafael Fajardo; Jorge Montalvo; David Velázquez; Jorge Arch; Paulina Bezaury; Rosa Gamino; Miguel F Herrera
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

3.  Adrenal pseudocyst: Diagnosis and laparoscopic management - A case report.

Authors:  Atheer B Ujam; Christopher J Peters; Paul J Tadrous; John Jeff Webster; Keith Steer; Alberto Martinez-Isla
Journal:  Int J Surg Case Rep       Date:  2011-10-12

Review 4.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 5.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

6.  1,161 patients with adrenal incidentalomas: indications for surgery.

Authors:  A A Kasperlik-Załuska; M Otto; A Cichocki; E Rosłonowska; J Słowinska-Srzednicka; W Zgliczyński; W Jeske; L Papierska; T Tołłoczko; J Polański; R Słapa
Journal:  Langenbecks Arch Surg       Date:  2007-11-10       Impact factor: 3.445

7.  Incidentally discovered adrenal myelolipoma associated with hyperthyroidism.

Authors:  Hisamitsu Ide; Yuichi Terado; Takashi Nakagawa; Keisuke Saito; Yutaka Kamiyama; Satoru Muto; Hiroshi Okada; Tetsuo Imamura; Shigeo Horie
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

Review 8.  Adrenal tumors: how to establish malignancy ?

Authors:  M Fassnacht; W Kenn; B Allolio
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

9.  Advances in biochemical screening for phaeochromocytoma using biogenic amines.

Authors:  Malcolm J Whiting; Matthew P Doogue
Journal:  Clin Biochem Rev       Date:  2009-02

10.  Solitary adrenal metastasis in a patient with sigmoid colon cancer; report of a case.

Authors:  Y Shoji; M Dohke; T Masuda; F Nakamura; T Yano; H Niizeki; N Kashimura; O Matsunami
Journal:  Int J Gastrointest Cancer       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.